Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13287 | 848 | 34.1 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
305 | 3 | NICOTINIC ACETYLCHOLINE RECEPTOR//BENZODIAZEPINES//NICOTINIC RECEPTORS | 40571 |
1459 | 2 | BENZODIAZEPINES//ZOLPIDEM//ZOPICLONE | 7774 |
13287 | 1 | ABECARNIL//PRECIPITATED ABSTINENCE//BENZODIAZEPINES | 848 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ABECARNIL | authKW | 396960 | 2% | 53% | 21 |
2 | PRECIPITATED ABSTINENCE | authKW | 216043 | 1% | 100% | 6 |
3 | BENZODIAZEPINES | authKW | 207676 | 19% | 4% | 160 |
4 | DIAZEPAM WITHDRAWAL | authKW | 200031 | 1% | 56% | 10 |
5 | BENZODIAZEPINE TOLERANCE | authKW | 192033 | 1% | 67% | 8 |
6 | FLURAZEPAM | authKW | 164582 | 2% | 29% | 16 |
7 | DIAZEPAM | authKW | 144932 | 11% | 4% | 90 |
8 | IMIDAZENIL | authKW | 138875 | 1% | 43% | 9 |
9 | BRETAZENIL | authKW | 136432 | 1% | 32% | 12 |
10 | CELLULAR MOL NEUROBIOL PROGRAM | address | 129621 | 1% | 60% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 13458 | 72% | 0% | 611 |
2 | Neurosciences | 5641 | 48% | 0% | 403 |
3 | Behavioral Sciences | 4940 | 17% | 0% | 148 |
4 | Psychiatry | 1773 | 17% | 0% | 146 |
5 | Substance Abuse | 143 | 2% | 0% | 18 |
6 | Clinical Neurology | 88 | 6% | 0% | 51 |
7 | Medicine, Research & Experimental | 32 | 4% | 0% | 30 |
8 | Psychology, Biological | 32 | 1% | 0% | 7 |
9 | Chemistry, Medicinal | 14 | 2% | 0% | 17 |
10 | Toxicology | 6 | 2% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELLULAR MOL NEUROBIOL PROGRAM | 129621 | 1% | 60% | 6 |
2 | AMBULATORIO ANSIEDADE | 36007 | 0% | 100% | 1 |
3 | BEHAV PHARMACOL PROGRAMADARC | 36007 | 0% | 100% | 1 |
4 | CHAIR NERVOUS DISORDERS | 36007 | 0% | 100% | 1 |
5 | HLTH SCI MED PHARMACOL4200 E 9TH AVE | 36007 | 0% | 100% | 1 |
6 | HUGO SACHS ELEKTRON SOLUT PHYSIOL | 36007 | 0% | 100% | 1 |
7 | IL 3 | 36007 | 0% | 100% | 1 |
8 | JOHNS HOPKINS BAYVIEW BEHAV BIOL | 36007 | 0% | 100% | 1 |
9 | NBC BRANCH | 36007 | 0% | 100% | 1 |
10 | NEUROSCI NEUROL DISORDERS PROGRAM | 36007 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 30803 | 12% | 1% | 103 |
2 | PSYCHOPHARMACOLOGY | 18583 | 9% | 1% | 79 |
3 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 12321 | 10% | 0% | 85 |
4 | BEHAVIOURAL PHARMACOLOGY | 10660 | 3% | 1% | 24 |
5 | EUROPEAN JOURNAL OF PHARMACOLOGY | 6591 | 8% | 0% | 72 |
6 | NEUROPHARMACOLOGY | 3657 | 4% | 0% | 31 |
7 | ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY | 3466 | 1% | 1% | 7 |
8 | EPILEPSY RESEARCH | 1319 | 1% | 0% | 12 |
9 | BIOCHEMICAL SOCIETY SYMPOSIUM | 1143 | 0% | 1% | 3 |
10 | RESEARCH COMMUNICATIONS IN ALCOHOL AND SUBSTANCES OF ABUSE | 835 | 0% | 2% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ABECARNIL | 396960 | 2% | 53% | 21 | Search ABECARNIL | Search ABECARNIL |
2 | PRECIPITATED ABSTINENCE | 216043 | 1% | 100% | 6 | Search PRECIPITATED+ABSTINENCE | Search PRECIPITATED+ABSTINENCE |
3 | BENZODIAZEPINES | 207676 | 19% | 4% | 160 | Search BENZODIAZEPINES | Search BENZODIAZEPINES |
4 | DIAZEPAM WITHDRAWAL | 200031 | 1% | 56% | 10 | Search DIAZEPAM+WITHDRAWAL | Search DIAZEPAM+WITHDRAWAL |
5 | BENZODIAZEPINE TOLERANCE | 192033 | 1% | 67% | 8 | Search BENZODIAZEPINE+TOLERANCE | Search BENZODIAZEPINE+TOLERANCE |
6 | FLURAZEPAM | 164582 | 2% | 29% | 16 | Search FLURAZEPAM | Search FLURAZEPAM |
7 | DIAZEPAM | 144932 | 11% | 4% | 90 | Search DIAZEPAM | Search DIAZEPAM |
8 | IMIDAZENIL | 138875 | 1% | 43% | 9 | Search IMIDAZENIL | Search IMIDAZENIL |
9 | BRETAZENIL | 136432 | 1% | 32% | 12 | Search BRETAZENIL | Search BRETAZENIL |
10 | PRECIPITATED WITHDRAWAL | 117738 | 1% | 30% | 11 | Search PRECIPITATED+WITHDRAWAL | Search PRECIPITATED+WITHDRAWAL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HUTCHINSON, MA , SMITH, PF , DARLINGTON, CL , (1996) THE BEHAVIOURAL AND NEURONAL EFFECTS OF THE CHRONIC ADMINISTRATION OF BENZODIAZEPINE ANXIOLYTIC AND HYPNOTIC DRUGS.PROGRESS IN NEUROBIOLOGY. VOL. 49. ISSUE 1. P. 73-97 | 81 | 70% | 65 |
2 | SMITH, PF , DARLINGTON, CL , (1994) THE BEHAVIORAL-EFFECTS OF LONG-TERM USE OF BENZODIAZEPINE SEDATIVE AND HYPNOTIC DRUGS - WHAT CAN BE LEARNED FROM ANIMAL STUDIES.NEW ZEALAND JOURNAL OF PSYCHOLOGY. VOL. 23. ISSUE 2. P. 48-63 | 69 | 78% | 3 |
3 | GRAVIELLE, MC , (2016) ACTIVATION-INDUCED REGULATION OF GABA(A) RECEPTORS: IS THERE A LINK WITH THE MOLECULAR BASIS OF BENZODIAZEPINE TOLERANCE?.PHARMACOLOGICAL RESEARCH. VOL. 109. ISSUE . P. 92 -100 | 50 | 49% | 2 |
4 | FILE, SE , (1990) THE HISTORY OF BENZODIAZEPINE DEPENDENCE - A REVIEW OF ANIMAL STUDIES.NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. VOL. 14. ISSUE 2. P. 135-146 | 53 | 79% | 81 |
5 | WRIGHT, BT , GLUSZEK, CF , HELDT, SA , (2014) THE EFFECTS OF REPEATED ZOLPIDEM TREATMENT ON TOLERANCE, WITHDRAWAL-LIKE SYMPTOMS, AND GABAA RECEPTOR MRNAS PROFILE EXPRESSION IN MICE: COMPARISON WITH DIAZEPAM.PSYCHOPHARMACOLOGY. VOL. 231. ISSUE 15. P. 2967 -2979 | 46 | 43% | 2 |
6 | PODHORNA, J , (2002) THE EXPERIMENTAL PHARMACOTHERAPY OF BENZODIAZEPINE WITHDRAWAL.CURRENT PHARMACEUTICAL DESIGN. VOL. 8. ISSUE 1. P. 23 -43 | 84 | 30% | 11 |
7 | ZANOTTI, A , NATOLINO, F , CONTARINO, A , LIPARTITI, M , GIUSTI, P , (1999) ABECARNIL ENHANCES RECOVERY FROM DIAZEPAM TOLERANCE.NEUROPHARMACOLOGY. VOL. 38. ISSUE 9. P. 1281-1288 | 30 | 88% | 4 |
8 | FAHEY, JM , PRITCHARD, GA , GRASSI, JM , PRATT, JS , SHADER, RI , GREENBLATT, DJ , (2001) PHARMACODYNAMIC AND RECEPTOR BINDING CHANGES DURING CHRONIC LORAZEPAM ADMINISTRATION.PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR. VOL. 69. ISSUE 1-2. P. 1-8 | 34 | 71% | 15 |
9 | LI, M , SZABO, A , ROSENBERG, HC , (2000) DOWN-REGULATION OF BENZODIAZEPINE BINDING TO ALPHA 5 SUBUNIT-CONTAINING GAMMA-AMINOBUTYRIC ACID(A) RECEPTORS IN TOLERANT RAT BRAIN INDICATES PARTICULAR INVOLVEMENT OF THE HIPPOCAMPAL CA1 REGION.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. VOL. 295. ISSUE 2. P. 689-696 | 31 | 79% | 19 |
10 | FERRERI, MC , GUTIERREZ, ML , GRAVIELLE, MC , (2015) TOLERANCE TO THE SEDATIVE AND ANXIOLYTIC EFFECTS OF DIAZEPAM IS ASSOCIATED WITH DIFFERENT ALTERATIONS OF GABA(A) RECEPTORS IN RAT CEREBRAL CORTEX.NEUROSCIENCE. VOL. 310. ISSUE . P. 152 -162 | 25 | 63% | 3 |
Classes with closest relation at Level 1 |